| Effect of Paracetamol on the Common Cold (NCT01277081) | GlaxoSmithKline | 2010-10-01 |
| A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children (NCT01198756) | GlaxoSmithKline | 2010-10-01 |
| Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database (NCT01376258) | GlaxoSmithKline | 2010-10-01 |
| Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients (NCT01431924) | GlaxoSmithKline | 2010-10-01 |
| A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults (NCT01196975) | GlaxoSmithKline | 2010-10-01 |
| An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain (NCT01205412) | GlaxoSmithKline | 2010-10-01 |
| Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation (NCT01431911) | GlaxoSmithKline | 2010-10-01 |
| A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) (NCT01178073) | GlaxoSmithKline | 2010-10-01 |
| A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function (NCT01287065) | GlaxoSmithKline | 2010-10-01 |
| Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia (NCT01236066) | GlaxoSmithKline | 2010-10-01 |
| Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population (NCT01337336) | GlaxoSmithKline | 2010-10-01 |
| Regulatory Hycamtin(Oral) PMS (NCT01037023) | GlaxoSmithKline | 2010-10-01 |
| The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women (NCT01381588) | GlaxoSmithKline | 2010-10-01 |
| Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics (NCT01357876) | GlaxoSmithKline | 2010-10-01 |
| An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt (NCT01158209) | GlaxoSmithKline | 2010-10-01 |
| Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children (NCT01195779) | GlaxoSmithKline | 2010-09-30 |
| A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A (NCT01318980) | GlaxoSmithKline | 2010-09-30 |
| Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects (NCT01165203) | GlaxoSmithKline | 2010-09-30 |
| Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants (NCT01204658) | GlaxoSmithKline | 2010-09-27 |
| Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™ (NCT01196026) | GlaxoSmithKline | 2010-09-15 |
| A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure (NCT01357850) | GlaxoSmithKline | 2010-09-15 |
| Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel (NCT01192165) | GlaxoSmithKline | 2010-09-14 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin (NCT01218204) | GlaxoSmithKline | 2010-09-14 |
| A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (NCT01254071) | GlaxoSmithKline | 2010-09-10 |
| Oral GW766944 (Oral CCR3 Antagonist) (NCT01160224) | GlaxoSmithKline | 2010-09-08 |
| Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528 (NCT01536574) | GlaxoSmithKline | 2010-09-02 |
| Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation (NCT01381458) | GlaxoSmithKline | 2010-09-01 |
| Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy (NCT01153932) | GlaxoSmithKline | 2010-09-01 |
| Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting (NCT01337323) | GlaxoSmithKline | 2010-09-01 |
| Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving (NCT01466361) | GlaxoSmithKline | 2010-09-01 |
| Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women (NCT01227928) | GlaxoSmithKline | 2010-09-01 |
| Drug Use Investigation for Cervarix® (NCT01187927) | GlaxoSmithKline | 2010-09-01 |
| Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age (NCT01156792) | GlaxoSmithKline | 2010-09-01 |
| Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy (NCT01587339) | GlaxoSmithKline | 2010-09-01 |
| Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA) (NCT01105936) | GlaxoSmithKline | 2010-09-01 |
| A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval. (NCT01721135) | GlaxoSmithKline | 2010-09-01 |
| Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma (NCT01181895) | GlaxoSmithKline | 2010-09-01 |
| VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK (NCT01205230) | GlaxoSmithKline | 2010-09-01 |
| A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity (NCT01205451) | GlaxoSmithKline | 2010-09-01 |
| A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan (NCT01202201) | GlaxoSmithKline | 2010-09-01 |
| A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours. (NCT01195792) | GlaxoSmithKline | 2010-09-01 |
| Effect of GSK962040 on Oesophageal Function (NCT01366560) | GlaxoSmithKline | 2010-08-31 |
| Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants (NCT01171963) | GlaxoSmithKline | 2010-08-29 |
| Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds (NCT01154088) | GlaxoSmithKline | 2010-08-27 |
| Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics (NCT01165138) | GlaxoSmithKline | 2010-08-20 |
| Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults (NCT01165242) | GlaxoSmithKline | 2010-08-19 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose (NCT01171989) | GlaxoSmithKline | 2010-08-18 |
| GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection (NCT01209078) | GlaxoSmithKline | 2010-08-17 |
| Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers (NCT01762787) | GlaxoSmithKline | 2010-08-17 |
| Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib (NCT01248897) | GlaxoSmithKline | 2010-08-17 |
| A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration (NCT01154062) | GlaxoSmithKline | 2010-08-16 |
| A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma (NCT01153763) | GlaxoSmithKline | 2010-08-09 |
| Helium-3 MRI Imaging Study in COPD (NCT02207452) | GlaxoSmithKline | 2010-08-05 |
| Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older (NCT01165229) | GlaxoSmithKline | 2010-08-02 |
| Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older (NCT01165177) | GlaxoSmithKline | 2010-08-02 |
| Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia (NCT01332487) | GlaxoSmithKline | 2010-08-01 |
| Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer (NCT01231581) | GlaxoSmithKline | 2010-08-01 |
| Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients (NCT01362283) | GlaxoSmithKline | 2010-08-01 |
| Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects (NCT01453296) | GlaxoSmithKline | 2010-08-01 |
| Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy (NCT01435954) | GlaxoSmithKline | 2010-08-01 |
| Fall Epidemic Viral Pediatric Study (NCT01192178) | GlaxoSmithKline | 2010-08-01 |
| Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD (NCT01254032) | GlaxoSmithKline | 2010-08-01 |
| Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM (NCT01160237) | GlaxoSmithKline | 2010-08-01 |
| A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD (NCT01192191) | GlaxoSmithKline | 2010-08-01 |
| Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children (NCT01148459) | GlaxoSmithKline | 2010-07-30 |
| A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers. (NCT01160003) | GlaxoSmithKline | 2010-07-29 |
| Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors (NCT01138033) | GlaxoSmithKline | 2010-07-27 |
| Japanese Phase I of GSK1605786 (NCT01611805) | GlaxoSmithKline | 2010-07-22 |
| Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery (NCT01159964) | GlaxoSmithKline | 2010-07-20 |
| Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) (NCT01381536) | GlaxoSmithKline | 2010-07-20 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults (NCT01160172) | GlaxoSmithKline | 2010-07-19 |
| Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease (NCT01124422) | GlaxoSmithKline | 2010-07-19 |
| Bioequivalence Study of Nimesulide 100 mg Tablets (NCT01745614) | GlaxoSmithKline | 2010-07-18 |
| Role of Early Versus Late Switch to Lapatinib-Capecitabine (NCT01357863) | GlaxoSmithKline | 2010-07-15 |
| Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose (NCT01119625) | GlaxoSmithKline | 2010-07-12 |
| A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects (NCT01128855) | GlaxoSmithKline | 2010-07-12 |
| Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years (NCT01153685) | GlaxoSmithKline | 2010-07-09 |
| A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease (NCT01114503) | GlaxoSmithKline | 2010-07-07 |
| Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants (NCT01098474) | GlaxoSmithKline | 2010-07-07 |
| Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer (NCT01149343) | GlaxoSmithKline | 2010-07-02 |
| Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females (NCT01101542) | GlaxoSmithKline | 2010-07-01 |
| Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Taiwan (NCT01072227) | GlaxoSmithKline | 2010-07-01 |
| Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures (NCT01227902) | GlaxoSmithKline | 2010-07-01 |
| Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects (NCT01154114) | GlaxoSmithKline | 2010-07-01 |
| Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines (NCT01144663) | GlaxoSmithKline | 2010-07-01 |
| A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma (NCT01244984) | GlaxoSmithKline | 2010-07-01 |
| Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old (NCT01161160) | GlaxoSmithKline | 2010-07-01 |
| A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics (NCT01147861) | GlaxoSmithKline | 2010-07-01 |
| A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole (NCT01165125) | GlaxoSmithKline | 2010-07-01 |
| Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents (NCT01159912) | GlaxoSmithKline | 2010-06-30 |
| Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily (NCT01147744) | GlaxoSmithKline | 2010-06-28 |
| Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects (NCT01435915) | GlaxoSmithKline | 2010-06-28 |
| Corrected QT (QTc) Study With Flucticasone Furoate and GW642444 (NCT01209026) | GlaxoSmithKline | 2010-06-23 |
| Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants (NCT01000974) | GlaxoSmithKline | 2010-06-18 |
| A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD) (NCT01138007) | GlaxoSmithKline | 2010-06-17 |
| A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults (NCT01144299) | GlaxoSmithKline | 2010-06-17 |
| Evaluation of Boostrix™10 Years After Previous Booster Vaccination (NCT01147900) | GlaxoSmithKline | 2010-06-15 |
| A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers (NCT01267071) | GlaxoSmithKline | 2010-06-14 |
| A Drug Interaction Study of Albiglutide and Digoxin (NCT01147718) | GlaxoSmithKline | 2010-06-11 |
| Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children (NCT01138098) | GlaxoSmithKline | 2010-06-07 |